The Implantable Cardiac Rhythm Management Device Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market size for the implantable cardiac rhythm management device has consistently expanded in recent years. It is projected to increase from $17.06 billion in 2024 to $17.87 billion in 2025, with a compound annual growth rate (CAGR) of 4.8%.
The Implantable Cardiac Rhythm Management Device Global Market is forecasted to reach $23.27 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.8%.
Download Your Free Sample of the 2025 Implantable Cardiac Rhythm Management Device Market Report and Uncover Key Trends Now!The key drivers in the implantable cardiac rhythm management device market are:
• The shift towards the use of leadless devices in cardiology
• Increased focus on heart failure management and remote patient monitoring
• The rising adoption of such devices in developing and emerging markets
• Increase in collaboration for research and development in this sector
The implantable cardiac rhythm management device market covered in this report is segmented –
1) By Device: Cardiac Resynchronization Therapy, Defibrillators, Pacemakers
2) By Application: Bradycardia, Tachycardia, Other Applications
3) By End-Use: Hospitals, Specialty Cardiac Centers, Other End-Uses
The key trends in the implantable cardiac rhythm management device market are:
• The transition towards leadless devices in cardiac management is a notable trend.
• Remote patient monitoring and the integration of telemedicine are becoming increasingly influential in the market.
• The emergence of bioresorbable technologies and the integration of AI are significant developments shaping the future.
• The sector is witnessing progress in the promise of wireless charging and power management for implantable devices.
The major players in the implantable cardiac rhythm management device market are:
• Schiller AG
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Koninklijke Philips N
North America was the largest region in the implantable cardiac rhythm management device market in 2024